Improved exercise tolerance after enzyme replacement therapy in Pompe disease

Med Sci Sports Exerc. 2012 May;44(5):771-5. doi: 10.1249/MSS.0b013e31823e6579.

Abstract

Purpose: Enzyme replacement therapy (ERT) has recently became available for Pompe disease. Data on the effects of ERT on physiological variables related to exercise tolerance have never been published.

Methods: Pulmonary gas exchange, cardiac output (by impedance cardiography), and vastus lateralis muscle O₂ extraction (by near-infrared spectroscopy) were determined during cycle ergometer exercise in a 50-yr-old patient before and after 1, 12, and 24 months of ERT.

Results: At the same constant-workload submaximal exercise, RPE, R, pulmonary ventilation, and HR were lower during ERT versus before, suggesting an increased exercise tolerance. Peak oxygen uptake (V˙O2peak) increased by ~35% from before (0.64 L·min⁻¹ or 11.4 mL·kg·min⁻¹) to 1 month (0.88 L·min⁻¹ or 15.7 mL·kg·min⁻¹) of treatment and did not significantly change thereafter. Also, peak cardiac output significantly increased during ERT, whereas peak skeletal muscle fractional O₂ extraction was unchanged compared with before.

Conclusions: Improvements of peak exercise capacity and exercise tolerance at submaximal workloads were observed in a patient with Pompe disease after 1 month of ERT, with no further changes during the ensuing treatment period (up to 24 months).

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiac Output / physiology
  • Enzyme Replacement Therapy*
  • Exercise Tolerance / physiology*
  • Female
  • Glycogen Storage Disease Type II / drug therapy*
  • Glycogen Storage Disease Type II / physiopathology*
  • Humans
  • Middle Aged
  • Muscle, Skeletal / physiology
  • Oxygen Consumption / physiology
  • Pulmonary Gas Exchange / physiology
  • Spectroscopy, Near-Infrared